Information Links
Mims
Main Navigation
Drugs
Conditions
News and resources
MIMS HostedNew drugs
Transdermal estradiol spray offers new treatment option for HRT
Lenzetto (estradiol) is the first transdermal spray...
Ketamine-derived nasal spray provides new option for resistant depression
Spravato (esketamine) works in a different way to existing...
New e-cigarette alternative launched on prescription
Voke, a new nicotine inhaler, is available to prescribe...
Low-dose oestrogen pessary for vaginal menopause symptoms
Imvaggis (estriol) is a new treatment for vaginal symptoms...
New low-dose oestrogen gel for vaginal menopause symptoms
Blissel is a topical gel containing 50 microgram/g...
Further monthly injectable migraine prophylactic launched
With the launch of Emgality (galcanezumab), prescribers...
New non-oestrogen treatment for vaginal menopause symptoms
Intrarosa (prasterone) is a new topical treatment for...
New migraine prophylactic for monthly or quarterly injection
Fremanezumab (Ajovy) is a monoclonal antibody licensed...
Licensed melatonin treatment now available for children with autism
GPs can now prescribe melatonin as a licensed prolonged-release...
Second DPP4 inhibitor/SGLT2 inhibitor tablet launched for patients with diabetes
Prescribers can now consider Glyxambi (linagliptin/empagliflozin)...
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
